BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36246828)

  • 1. Alpha-fetoprotein-producing hepatoid adenocarcinoma of the lung responsive to sorafenib after multiline treatment: A case report.
    Xu SZ; Zhang XC; Jiang Q; Chen M; He MY; Shen P
    World J Clin Cases; 2022 Oct; 10(28):10236-10243. PubMed ID: 36246828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel approach using sorafenib in alpha fetoprotein-producing hepatoid adenocarcinoma of the lung.
    Gavrancic T; Park YH
    J Natl Compr Canc Netw; 2015 Apr; 13(4):387-91; quiz 391. PubMed ID: 25870375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-PD-1 Therapy Achieved Disease Control After Multiline Chemotherapy in Unresectable
    Chen L; Han X; Gao Y; Zhao Q; Wang Y; Jiang Y; Liu S; Wu X; Miao L
    Onco Targets Ther; 2020; 13():4359-4364. PubMed ID: 32547068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatoid Adenocarcinoma of the Lung: A Systematic Review of the Literature From 1981 to 2020.
    Hou Z; Xie J; Zhang L; Dai G; Chen Y; He L
    Front Oncol; 2021; 11():702216. PubMed ID: 34422656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatoid adenocarcinoma of the lung without production of α-fetoprotein: A case report and review of the literature.
    Sun JN; Zhang BL; Li LK; Yu HY; Wang B
    Oncol Lett; 2016 Jul; 12(1):189-194. PubMed ID: 27347123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatoid Adenocarcinoma of the Lung.
    Li M; Fan Y; Lu H
    Technol Cancer Res Treat; 2021; 20():15330338211057983. PubMed ID: 34816785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatoid adenocarcinoma of the lung with PD-L1 expression and the response to anti-PD-1 therapy: a case report.
    Li Y; Liu L; Wang D; Tan X; Sui Y; Yang H
    Front Oncol; 2023; 13():1257931. PubMed ID: 38074660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-fetoprotein-producing gastric carcinoma: A case report of a rare subtype and literature review.
    Sun N; Sun Q; Liu Q; Zhang T; Zhu Q; Wang W; Cao M; Zang QI
    Oncol Lett; 2016 May; 11(5):3101-3104. PubMed ID: 27123071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary hepatoid adenocarcinoma of the lung in Yungui Plateau, China: A case report.
    Shi YF; Lu JG; Yang QM; Duan J; Lei YM; Zhao W; Liu YQ
    World J Clin Cases; 2019 Jul; 7(13):1711-1716. PubMed ID: 31367631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Merged hepatopulmonary features in hepatoid adenocarcinoma of the lung: a systematic review.
    Mao JX; Liu C; Zhao YY; Ding GS; Ma JQ; Teng F; Guo WY
    Am J Transl Res; 2021; 13(3):898-922. PubMed ID: 33841629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatoid adenocarcinoma of the lung: Presenting mediastinal metastasis without transfer to the liver.
    Che YQ; Wang S; Luo Y; Wang JB; Wang LH
    Oncol Lett; 2014 Jul; 8(1):105-110. PubMed ID: 24959228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatoid Adenocarcinoma of the Lung Responsive to Frontline Combination Chemotherapy With Immunotherapy: Case Report.
    Lagos GG; Feldman JL; Saqi A; Shu CA
    JTO Clin Res Rep; 2021 Feb; 2(2):100130. PubMed ID: 34589989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of Hepatoid adenocarcinoma of the lung: Four case reports and literature review.
    Zhuansun Y; Bian L; Zhao Z; Du Y; Chen R; Lin L; Li J
    Cancer Treat Res Commun; 2021; 29():100474. PubMed ID: 34656923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic Profiles of a Patient of Pulmonary Hepatoid Adenocarcinoma With High AFP Level: A Case Report.
    Li J; Qi H; Xu B; Zhao J; Gao H; Ma X; Liu X
    Front Oncol; 2019; 9():1360. PubMed ID: 31921629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant mixed Mullerian tumor of the uterine corpus with alpha-fetoprotein-producing hepatoid adenocarcinoma component.
    Takano M; Shibasaki T; Sato K; Aida S; Kikuchi Y
    Gynecol Oncol; 2003 Nov; 91(2):444-8. PubMed ID: 14599882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-Fetoprotein-Producing Lung Hepatoid Adenocarcinoma with Brain Metastasis Treated with S-1.
    Muroyama Y; Tamiya H; Tanaka G; Tanaka W; Huang AC; Oldridge DA; Matsusaka K; Takazawa Y; Jo T; Ushiku T; Nagase T
    Case Rep Oncol; 2020; 13(3):1552-1559. PubMed ID: 33564297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-exome sequencing and bioinformatics analysis of a case of non-alpha-fetoprotein-elevated lung hepatoid adenocarcinoma.
    Yao Y; Guan X; Bao G; Liang J; Li T; Zhong X
    Front Pharmacol; 2022; 13():945038. PubMed ID: 36091765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatoid adenocarcinoma of the lung: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database.
    Lei L; Yang L; Xu YY; Chen HF; Zhan P; Wang WX; Xu CW
    Open Med (Wars); 2021; 16(1):169-174. PubMed ID: 33585692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary pulmonary hepatoid adenocarcinoma: A case report and review of the literature.
    Yang K; Jiang H; Li Q
    Medicine (Baltimore); 2019 Apr; 98(14):e15053. PubMed ID: 30946350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary α-fetoprotein positive hepatoid adenocarcinoma of the lung: a case report].
    Zhang K; Liu Q; Liu B; Lin D
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Jul; 46(7):700-707. PubMed ID: 37402661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.